310.36
Veeva Systems Inc stock is traded at $310.36, with a volume of 1.73M.
It is down -0.85% in the last 24 hours and up +17.16% over the past month.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
See More
Previous Close:
$313.03
Open:
$319.95
24h Volume:
1.73M
Relative Volume:
1.11
Market Cap:
$50.25B
Revenue:
$3.32B
Net Income/Loss:
$941.65M
P/E Ratio:
55.26
EPS:
5.6161
Net Cash Flow:
$1.64B
1W Performance:
+4.81%
1M Performance:
+17.16%
6M Performance:
+85.08%
1Y Performance:
+6.02%
Veeva Systems Inc Stock (VEEV) Company Profile
Name
Veeva Systems Inc
Sector
Industry
Phone
925-452-6500
Address
4280 HACIENDA DRIVE, PLEASANTON, CA
Compare VEEV vs BTSG, TEM, HNGE, HQY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
VEEV
Veeva Systems Inc
|
310.36 | 50.25B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
60.87 | 12.04B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
64.72 | 11.75B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HNGE
Hinge Health Inc
|
99.16 | 8.00B | 646.34M | -512.40M | 202.76M | -6.6871 |
|
HQY
Healthequity Inc
|
92.03 | 7.61B | 1.34B | 230.70M | 440.96M | 2.6695 |
Veeva Systems Inc Stock (VEEV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-24-26 | Resumed | Piper Sandler | Overweight |
| Jul-23-26 | Initiated | Guggenheim | Buy |
| Apr-10-26 | Downgrade | Citigroup | Buy → Neutral |
| Feb-17-26 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jan-13-26 | Resumed | Goldman | Sell |
| Jan-08-26 | Upgrade | Truist | Hold → Buy |
| Dec-12-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-07-25 | Upgrade | TD Cowen | Hold → Buy |
| Sep-08-25 | Upgrade | JP Morgan | Neutral → Overweight |
| May-29-25 | Reiterated | Needham | Buy |
| Jan-23-25 | Downgrade | Goldman | Buy → Sell |
| Dec-20-24 | Initiated | Stephens | Overweight |
| Dec-04-24 | Initiated | Mizuho | Outperform |
| Nov-19-24 | Initiated | Scotiabank | Sector Perform |
| Oct-08-24 | Initiated | Exane BNP Paribas | Outperform |
| Aug-27-24 | Reiterated | Citigroup | Buy |
| Jul-09-24 | Initiated | BTIG Research | Buy |
| Oct-25-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-13-23 | Initiated | Jefferies | Buy |
| Jun-28-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jun-01-23 | Upgrade | Guggenheim | Neutral → Buy |
| Mar-17-23 | Downgrade | Truist | Buy → Hold |
| Feb-23-23 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-04-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-06-22 | Initiated | Cowen | Market Perform |
| Dec-02-22 | Reiterated | Needham | Buy |
| Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-19-22 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-27-22 | Initiated | Oppenheimer | Outperform |
| Jun-23-22 | Initiated | Goldman | Buy |
| Jun-21-22 | Resumed | Guggenheim | Buy |
| Mar-03-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-28-22 | Initiated | Truist | Buy |
| Jan-07-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-06-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-01-21 | Resumed | Stifel | Buy |
| Sep-02-21 | Reiterated | BofA Securities | Buy |
| Sep-02-21 | Reiterated | JMP Securities | Mkt Outperform |
| Sep-02-21 | Reiterated | Needham | Buy |
| Sep-02-21 | Reiterated | UBS | Neutral |
| Jul-21-21 | Initiated | Cowen | Outperform |
| Mar-31-21 | Upgrade | UBS | Sell → Neutral |
| Jan-07-21 | Resumed | KeyBanc Capital Markets | Overweight |
| Dec-09-20 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-14-20 | Resumed | UBS | Sell |
| Aug-28-20 | Reiterated | Needham | Buy |
| Jul-23-20 | Initiated | FBN Securities | Outperform |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Jun-08-20 | Initiated | Citigroup | Buy |
| May-29-20 | Reiterated | Needham | Buy |
| Apr-13-20 | Initiated | SVB Leerink | Mkt Perform |
| Feb-19-20 | Initiated | Robert W. Baird | Outperform |
| Feb-14-20 | Initiated | Piper Sandler | Overweight |
| Jan-13-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-27-19 | Reiterated | Canaccord Genuity | Hold |
| Sep-26-19 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Aug-28-19 | Reiterated | Needham | Buy |
| Jun-07-19 | Initiated | Goldman | Neutral |
| May-30-19 | Reiterated | BofA/Merrill | Buy |
| May-30-19 | Upgrade | Stephens | Equal-Weight → Overweight |
| May-24-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-17-19 | Reiterated | Needham | Buy |
| Feb-27-19 | Reiterated | Needham | Buy |
View All
Veeva Systems Inc Stock (VEEV) Latest News
Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know - Zacks Investment Research
iOnctura appoints Paul Sekhri as Chair of its Board of Directors - GlobeNewswire Inc.
VEEV Expands IQVIA Partnership With Clinical Operations Software Suite - Zacks Investment Research
$1000 Invested In Veeva Systems 10 Years Ago Would Be Worth This Much Today - Benzinga
Veeva Systems (VEEV) Increases Despite Market Slip: Here's What You Need to Know - Yahoo! Finance Canada
Veeva Systems (VEEV) Increases Despite Market Slip: Here's What You Need to Know - Zacks Investment Research
Veeva Systems (VEEV) Stock Trades Up, Here Is Why - Yahoo Finance
Seilern Investment Management Ltd Sells 138,217 Shares of Veeva Systems Inc. $VEEV - MarketBeat
Veeva Systems stock hits 52-week high at 302.87 USD - Investing.com
Veeva Systems (NYSE:VEEV) Hits New 12-Month HighHere's What Happened - MarketBeat
Veeva Systems' Basics Gains Traction With 175+ Emerging Biotech Firms - TradingView
Veeva Systems' Basics Gains Traction With 175+ Emerging Biotech Firms - Zacks Investment Research
IQVIA Selects Veeva Systems Clinical Operations Applications - marketscreener.com
IQVIA Selects Veeva Clinical Operations Applications – Company Announcement - Financial Times
Form 4 Veeva Systems Inc For: 12 October By Investing.com - Investing.com Nigeria
Form 4 Veeva Systems Inc For: 12 October By Investing.com - Investing.com Canada
Veeva Systems’ (VEEV) Comeback Gets Jim Cramer Talking - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Henry Schein (HSIC), Veeva Systems (VEEV) and Bristol-Myers Squibb (BMY) - The Globe and Mail
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now - Zacks Investment Research
Veeva Systems (NYSE:VEEV) Upgraded to Buy at Wall Street Zen - MarketBeat
Veeva Systems Inc (VEEV) Stock Up 4.0% but GF Value Says Overval - GuruFocus
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now - Zacks Investment Research
Vilga Financial Planning LLC Purchases 6,000 Shares of Veeva Systems Inc. $VEEV - MarketBeat
Global Decentralized Clinical Trials Market Size, Trends, and Forecast, 2025-2030 | AI, Wearables, and Cloud-Based Platforms Fuel 13.7% CAGR to $18.8 Billion - GlobeNewswire Inc.
Bell Asset Management Ltd Decreases Stock Position in Veeva Systems Inc. $VEEV - MarketBeat
5,900 Shares in Veeva Systems Inc. $VEEV Acquired by Westwind Capital - MarketBeat
Veeva Summit to Showcase AI Innovations and the Leaders Transforming R&D and Quality - Yahoo Finance
Wealth Enhancement Trust Services Inc. Buys 3,933 Shares of Veeva Systems Inc. $VEEV - MarketBeat
Veeva Systems Inc. (VEEV) Stock Forecasts - Yahoo Finance
Veeva Systems Announces More Than 175 Emerging Biotechs Standardize On Veeva Basics To Accelerate Drug Development - marketscreener.com
Veeva's DQS Scales Data Automation Across 1,000+ Clinical Studies - Zacks Investment Research
Veeva's DQS Scales Data Automation Across 1,000+ Clinical Studies - TradingView
Veeva Systems Announces Veeva DQS Cleans Data For More Than 1 Million Subjects Across Over 1,000 Studies - marketscreener.com
Sites and sponsors saved thousands of hours on trial data cleanup with Veeva. - Stock Titan
Is VanEck Morningstar Wide Moat ETF (MOAT) a Strong ETF Right Now? - Zacks Investment Research
ETFs Investing in Veeva Systems Inc. Class A Stocks - TradingView
Veeva Systems Inc (VEEV) Shares Surge 3.7% -- What GF Score of 99 Tells Investors - GuruFocus
Veeva Systems (NYSE:VEEV) EVP Daniel Rizzo Sells 4,841 Shares of Company Stock - MarketBeat
Veeva Systems (VEEV) withholds 705 shares for taxes as its CFO converts stock grants. - Stock Titan
For taxes, Veeva Systems (VEEV) withholds 1,272 shares from Schwenger’s stock award conversion. - Stock Titan
After 854 shares were withheld for taxes, Veeva Systems (VEEV) EVP Rizzo sold 4,520 and 321 shares. - Stock Titan
Accounting chief acquires 168 Veeva Systems (VEEV) shares; 61 are withheld for taxes. - Stock Titan
Following a $9.01M August sale, a former officer proposes another at Veeva Systems (NYSE: VEEV). - Stock Titan
Rockland Trust Co. Reduces Holdings in Veeva Systems Inc. $VEEV - MarketBeat
43,000 Veeva Systems Inc. $VEEV Shares Sold by Bright Rock Capital Management LLC - MarketBeat
Veeva's OpenData to Help Servier Build a Global AI Data Foundation - TradingView
Company News for Oct 5, 2026 - Zacks Investment Research
Veeva Systems Inc. (VEEV) Stock Forecasts - Yahoo! Finance Canada
Veeva Systems Inc. (VEEV) stock price, news, quote and history - Yahoo Finance Australia
Veeva Systems Inc (VEEV) Stock Down 3.0% -- Now Undervalued? GF Score: 99/100 - GuruFocus
Veeva Systems Inc Stock (VEEV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Veeva Systems Inc Stock (VEEV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| THOMAS SCHWENGER | Former Affiliate |
Oct 15 '26 |
Proposed Sale |
300.00 |
3,000 |
900,000 |
0 |
| THOMAS SCHWENGER | Former Officer |
Oct 15 '26 |
Proposed Sale |
300.00 |
2,485 |
745,500 |
0 |
| Faddis Jonathan | Officer |
Oct 14 '26 |
Proposed Sale |
299.72 |
5,198 |
1,557,920 |
0 |
| THOMAS SCHWENGER | Former Officer |
Oct 14 '26 |
Proposed Sale |
296.42 |
6,695 |
1,984,498 |
0 |
| THOMAS SCHWENGER | Former Officer |
Oct 05 '26 |
Proposed Sale |
279.73 |
132,751 |
37,134,887 |
0 |
| DANIEL RIZZO | Officer |
Oct 02 '26 |
Proposed Sale |
276.51 |
4,841 |
1,338,578 |
0 |
| Rizzo Daniel J | EVP, Sales, Consulting, & Svcs |
Oct 02 '26 |
Sale |
276.51 |
4,841 |
1,338,578 |
7,665 |
| Schwenger Thomas D. | Pres. & Chief Customer Officer |
Oct 01 '26 |
Option Exercise |
0.00 |
2,907 |
0 |
21,356 |
| Van Wagener Brian | Chief Financial Officer |
Oct 01 '26 |
Option Exercise |
0.00 |
1,636 |
0 |
10,961 |
| Zuppas Eleni Nitsa | President & Chief of Staff |
Oct 01 '26 |
Option Exercise |
0.00 |
2,181 |
0 |
35,599 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):